AI, Neuroscience and GLP-1s Will Maintain Momentum: Expert Panel

Biotech in 2023 had an eventful—to say the least—spell with a market that was still recovering, and topics such as weight loss and artificial intelligence took on a new prevalence in the industry’s lexicon. Speaking at an event hosted by consulting company Boston Consulting Group on Tuesday, several experts provided their views on what the industry can expect in 2024.